ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $401,000 | -72.5% | 16,447 | -83.9% | 0.16% | -79.4% |
| Q4 2018 | $1,458,000 | -14.9% | 102,345 | -9.2% | 0.77% | +1.2% |
| Q3 2018 | $1,713,000 | +25.4% | 112,700 | +38.4% | 0.76% | +28.7% |
| Q2 2018 | $1,366,000 | +17.3% | 81,416 | +14.0% | 0.59% | +36.1% |
| Q1 2018 | $1,165,000 | +79.8% | 71,400 | +41.1% | 0.44% | +119.7% |
| Q4 2017 | $648,000 | -42.1% | 50,600 | -44.4% | 0.20% | -41.6% |
| Q3 2017 | $1,119,000 | +59.6% | 91,000 | +8.7% | 0.34% | +71.2% |
| Q2 2017 | $701,000 | +183.8% | 83,700 | +197.9% | 0.20% | +94.1% |
| Q4 2016 | $247,000 | +263.2% | 28,100 | +181.0% | 0.10% | +308.0% |
| Q3 2016 | $68,000 | – | 10,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,169,276 | $66,110,000 | 11.67% |
| Redmile Group, LLC | 13,623,620 | $98,226,000 | 8.05% |
| First Light Asset Management, LLC | 849,374 | $6,124,000 | 2.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,529,361 | $68,707,000 | 2.29% |
| Opus Point Partners Management, LLC | 320,000 | $2,307,000 | 1.83% |
| KOPP INVESTMENT ADVISORS LLC | 383,022 | $2,762,000 | 1.23% |
| Artal Group S.A. | 3,710,000 | $26,749,000 | 1.15% |
| EcoR1 Capital, LLC | 400,000 | $2,884,000 | 0.96% |
| Cormorant Asset Management, LP | 850,000 | $6,129,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,768,000 | 0.56% |